Boehringer Ingelheim, Sanofi Agree to $25 billion Business Unit Swap

SUGAR LAND--June 28, 2016--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--France's drug giant, Sanofi (NASDAQ:SNY) (Paris, France), and Germany's privately held Boehringer Ingelheim (BI) (Ingelheim, Germany) have engineered a $25 billion agreement to trade Sanofi's Merial animal drugs business with Boehringer's Consumer Health Care (CHC) over-the-counter (OTC) group. First discussed in late 2015, the deal should close by the end of the year. Within this article: Details of the planned business unit swap between Sanofi and Boehringer Ingelheim.